Hangzhou Biotest Biotech Co Ltd (688767) — Cash Flow Quality Index
Hangzhou Biotest Biotech Co Ltd (688767) has a Cash Flow Quality Index of 2.88x as of September 2025. Operating cash flow of CN¥28.39 Million exceeds net income of CN¥9.86 Million, indicating high earnings quality where cash backs reported profits. Explore 688767 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hangzhou Biotest Biotech Co Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Hangzhou Biotest Biotech Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Hangzhou Biotest Biotech Co Ltd operating cash flow efficiency.
Annual Cash Flow Quality Index for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year earnings quality comparison for Hangzhou Biotest Biotech Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.16x | CN¥106.47 Million | CN¥49.25 Million | ▲ +179.8% |
| 2024 | 0.77x | CN¥128.83 Million | CN¥166.78 Million | ▼ -37.3% |
| 2023 | 1.23x | CN¥131.38 Million | CN¥106.61 Million | ▲ +35.6% |
| 2022 | 0.91x | CN¥703.21 Million | CN¥773.58 Million | ▼ -16.3% |
| 2021 | 1.09x | CN¥908.12 Million | CN¥835.76 Million | ▲ +6.0% |
| 2020 | 1.03x | CN¥446.07 Million | CN¥434.97 Million | ▲ +11.6% |
| 2019 | 0.92x | CN¥25.67 Million | CN¥27.94 Million | ▼ -18.2% |
| 2018 | 1.12x | CN¥21.17 Million | CN¥18.85 Million | ▼ -46.7% |
| 2017 | 2.11x | CN¥7.07 Million | CN¥3.36 Million | — |